Inventor · disambiguated record
Xichen Lin
Also filed as: LIN XICHEN
22 granted patents·25 pending applications·41 citations·filing 2004–2024
92Inventor score
Files withGASHERBRUM BIO INC16GLAXO GROUP LTD8GLAXOSMITHKLINE IP DEV LTD4SMITHKLINE BEECHAM CORP4CALLAHAN JAMES F3
Top patents by PatentIndex Score
47 records- 0194US11926626B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Mar 12, 2024·7 cites·23 claims
- 0294US11492365B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Nov 8, 2022·6 cites·15 claims
- 0393US12221442B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2024·Granted Feb 11, 2025·3 cites·4 claims
- 0492US11897851B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2023·Granted Feb 13, 2024·3 cites·5 claims
- 0583US7479558B2Process for preparing pyrido[2,3-d]pyrimidin-7-one and 3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one derivativesGLAXO GROUP LTD·Filed 2006·Granted Jan 20, 2009·5 cites·69 claims
- 0682US2025115606A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2024·Application pending·0 cites
- 0780US8354406B2Chemical compoundsGLAXOSMITHKLINE LLC·Filed 2011·Granted Jan 15, 2013·6 cites·23 claims
- 0875US7858796B2Chemical compoundsGLAXO GROUP LTD·Filed 2005·Granted Dec 28, 2010·3 cites·32 claims
- 0975US7678801B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Mar 16, 2010·2 cites·76 claims
- 1075US2023071840A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2022·Application pending·0 cites
- 1172US7674789B2CompoundsGLAXO GROUP LTD·Filed 2006·Granted Mar 9, 2010·1 cites·71 claims
- 1271US11926643B2Heterocyclic GLP-1 agonistsGASHERBRUM BIO INC·Filed 2022·Granted Mar 12, 2024·0 cites·20 claims
- 1367US8071584B2Indole carboxamides as IKK2 inhibitorsBOEHM JEFFREY CHARLES·Filed 2008·Granted Dec 6, 2011·2 cites·24 claims
- 1465US8207176B2CompoundsCALLAHAN JAMES F·Filed 2006·Granted Jun 26, 2012·1 cites·31 claims
- 1564US8354416B27,8-dihydropyrido[2,3-d]pyrimidin-4-yl substituted compounds as inhibitors of p38 kinaseGLAXO GROUP LTD·Filed 2008·Granted Jan 15, 2013·0 cites·30 claims
- 1661US8389508B2Heterocyclic compoundsDENG GUANGHUI·Filed 2011·Granted Mar 5, 2013·2 cites·9 claims
- 1761US2023295154A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 1860US2025250269A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2023·Application pending·0 cites
- 1960US2025206757A15,8-dihydro-1,7-naphthyridine derivatives as glp-1 agonists for the treatment of diabetesGASHERBRUM BIO INC·Filed 2023·Application pending·0 cites
- 2059US2009239897A1Novel compoundsSMITHKLINE BEECHAM CORP·Filed 2009·Application pending·0 cites
- 2159US2010093765A1Novel compoundsCALLAHAN JAMES F·Filed 2009·Application pending·0 cites
- 2259US2010093766A1Novel compoundsCALLAHAN JAMES F·Filed 2009·Application pending·0 cites
- 2358US2009048444A1Process for Preparing Pyrido[2,3-d]pyrimidin-7-one and 3,4-Dihydropyrimido[4,5-d]pyrimidin-2(1H)-one DerivativesGLAXO GROUP LTD·Filed 2008·Application pending·0 cites
- 2458US2024366639A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2022·Application pending·0 cites
- 2555US2023391760A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 2653US2024083886A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 2753US2023322771A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 2852US7550480B2CompoundsSMITHKLINE BEECHAM CORP·Filed 2004·Granted Jun 23, 2009·0 cites·21 claims
- 2951US2024018102A1Compounds and compositions for treating conditions associated with lpa receptor activityLHOTSE BIO INC·Filed 2021·Application pending·0 cites
- 3050US2023165846A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2021·Application pending·0 cites
- 3149US2025188103A1Heterocyclic glp-1 agonistsGASHERBRUM BIO INC·Filed 2023·Application pending·0 cites
- 3246US8217028B21,2,4-oxadiazole indole compoundsCASTRO PINEIRO JOSE LUIS·Filed 2009·Granted Jul 10, 2012·0 cites·4 claims
- 3345US10336719B21-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jul 2, 2019·0 cites·15 claims
- 3445US2008262040A1Chemical CompoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 3544US2008242685A1Chemical CompoundsSMITHKLINE BEECHAM CORP·Filed 2006·Application pending·0 cites
- 3640US10005731B2Modulators of the retinoid-related orphan receptor gamma (ROR-gamma) for use in the treatment of autoimmune and inflammatory diseasesGLAXO GROUP LTD·Filed 2013·Granted Jun 26, 2018·0 cites·19 claims
- 3738US2013012491A1Pyrimidine derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonistsGLAXO GROUP LTD·Filed 2011·Application pending·0 cites
- 3836US10106515B21-(cyclopent-2-en-1-yl)-3-(2-hydroxy-3-(arylsulfonyl)phenyl)urea derivatives as CXCR2 inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Oct 23, 2018·0 cites·12 claims
- 3935US9868724B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jan 16, 2018·0 cites·21 claims
- 4034US9902715B2CompoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Feb 27, 2018·0 cites·21 claims
- 4134US2012283297A1Oxadiazole substituted indazole derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonistsBAILEY JAMES·Filed 2010·Application pending·0 cites
- 4232US2012101123A1CompoundsLI CHENGYONG·Filed 2010·Application pending·0 cites
- 4328US9902735B2Heteroaryl substituted compounds as RORγ inhibitorsGLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPEMENT LTD·Filed 2015·Granted Feb 27, 2018·0 cites·13 claims
- 4428US2012101124A11,2,4-oxadiazol derivatives, their pharmaceutical compositions and their use as sphingosine 1-phosphate 1 receptor agonistsLIN XICHEN·Filed 2010·Application pending·0 cites
- 4528US2012094979A1Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonistsBAILEY JAMES MATTHEW·Filed 2010·Application pending·0 cites
- 4627US2012101134A15-membered heteroaryl derivatives used as sphingosine 1-phosphate receptor agonistsDENG GUANGHUI·Filed 2010·Application pending·0 cites
- 4726US2012101136A15-membered heteroaryl derivatives used as sphingosine 1- phosphate receptor agonistsDENG GUANGHUI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Xichen Lin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →